Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 3/20 | 0.55 |
| ▸ | CNR2 | P34972 | 7/20 | 0.54 |
| ▸ | CNR1 | P21554 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | FABP4 | P15090 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6331989 | 0.90 | MAPT (0.51) | MTNR1ACNR2CNR1MAPTTUBB1 | |
| SCHEMBL6331985 | 0.90 | CNR2 (0.54) | MTNR1ACNR2CNR1MAPTTUBB1 | |
| SCHEMBL21777692 | 0.81 | TSHR (0.60) | CNR2CNR1MAPTRAB9ATSHR | |
| SCHEMBL31435515 | 0.79 | RAB9A (0.63) | TUBB1RAB9ATSHRL3MBTL1ALDH1A1 | |
| SCHEMBL3327762 | 0.75 | MTNR1A (0.70) | MTNR1ACNR2MAPTRAB9AL3MBTL1 | |
| SCHEMBL10856546 | 0.75 | MTNR1A (0.70) | MTNR1ACNR2ALDH1A1HPGDMAOB | |
| SCHEMBL31392475 | 0.75 | MTNR1A (0.70) | MTNR1ACNR2ALDH1A1HPGDMAOB | |
| SCHEMBL29140999 | 0.74 | MTNR1A (0.68) | MTNR1ACNR2ALDH1A1KDM4E | |
| SCHEMBL22956030 | 0.73 | OXER1 (0.50) | CNR2MAPTRAB9ATSHRL3MBTL1 | |
| SCHEMBL830122 | 0.73 | MTNR1A (0.67) | MTNR1ACNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050009903-A1 | CB2-selective cannabinoid analogues | CLEMSON UNIVERSITY | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009903-A1 | CB2-selective cannabinoid analogues | CNR2, CNR1, GPR68 | MTNR1A 25/4885CNR2 1/4885CNR1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.